Charts Are Looking up for Biotech ETFs

After a volatile summer, the iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB) has rebounded somewhat to gain 3.7% over the past month. Though modest by the standards of IBB and rival biotechnology exchange traded funds, the ETF’s recent bullishness could be a harbinger of more significant...